Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
RIGEL PHARMACEUTICALS INC
| Metric | RIGEL PHARMACEUTICALS INC RIGLOther |
|---|---|
| Quality Score | 68 / 100 |
| Revenue (latest) | $294M |
| Net income (latest) | $367M |
| Operating margin | 42.6% |
| Net margin | 124.7% |
| Return on equity | 93.8% |
| Return on assets | 71.5% |
| Return on capital (ROCE) | 30.3% |
| Debt / equity | 0.31× |
| Revenue growth (YoY) | 64.1% |
| Altman Z″ (distress) | 0.31 |
| Accruals / assets | 56.7% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.